Financhill
Back

Amicus Therapeutics Stock Predictions

Amicus Therapeutics Stock Forecast

  • Over the next 52 weeks, Amicus Therapeutics has on average historically risen by 12.7% based on the past 17 years of stock performance.
  • Amicus Therapeutics has risen higher in 6 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 35.29%
  • Is Amicus Therapeutics Stock Undervalued?
    The current Amicus Therapeutics [FOLD] share price is $9.66. The Score for FOLD is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • FOLD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Amicus Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Amicus Therapeutics has on average historically risen by 12.7% based on the past 17 years of stock performance.

Amicus Therapeutics Stock Rating

Sell
29
Amicus Therapeutics (FOLD) is a Sell

Is Amicus Therapeutics overpriced?

  • Amicus Therapeutics has risen higher in 6 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 35.29%

Amicus Therapeutics Stock Price History

Is FOLD stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FOLD is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
amicusrx.com

52-Week Data

52-Week High:
14.57
52-Week Low:
9.02

Prediction Charts

Market Cap:
2.89B
Price in USD:
9.66
Volume:
1.92M
Beta:
1.02

Technical Analysis

SMA50:
10.81
SMA100:
10.86
SMA200:
10.98
52-Wk Change:
-9.21%

Stock Predictions

  • Is Amicus Therapeutics stock public?
    Yes, Amicus Therapeutics is a publicly traded company.
  • What is the Amicus Therapeutics stock quote today?
    The Amicus Therapeutics stock price is 9.66 USD today.
  • How to buy Amicus Therapeutics stock online?
    You can buy Amicus Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-5 11.24 11.74 11.75 11.21
Nov-6 12.53 11.23 12.65 10.92
Nov-7 11.24 10.97 11.25 10.73
Nov-8 11.00 10.99 11.36 10.94
Nov-11 11.09 10.69 11.14 10.66
Nov-12 10.69 10.49 10.83 10.43
Nov-13 10.57 10.38 10.66 10.30
Nov-14 10.38 10.09 10.43 10.06
Nov-15 10.13 9.68 10.13 9.64
Nov-18 9.93 9.66 10.04 9.60
Nov-19 9.37 9.52 9.56 9.37
Nov-20 9.49 9.59 9.68 9.38
Nov-21 9.62 9.50 9.64 9.39
Nov-22 9.51 9.66 9.78 9.46

Amicus Therapeutics Earnings

Amicus Therapeutics Earnings Report: Per Share Amicus Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Amicus Therapeutics Forecast Revenue Growth

Amicus Therapeutics Stock Analysis: Historical quarterly revenues per share for Amicus Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.57 per share, and an increase next year of $0.21 per share.

* Amicus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.